Dale Abel
Tue 21 14:30
S30.1
Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Julio Abucham
Tue 21 08:00
MTE16.1
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Peter Aldiss
Mon 20 10:20
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Dr Cynthia Andoniadou
London, UK
Mon 20 15:30
S17.2
Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
London, UK
Carmen Aresta
Mon 20 12:00
OC7.1
Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Alberto Arias
Mon 20 13:00
ERN1.1
Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Mai Arlien-Søborg
Sun 19 12:36
OC3.4
Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Guillaume Assie
Tue 21 09:50
S24.1
Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Marta Astigarraga
Sun 19 12:00
OC4.1
Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Fereidoun Azizi
Mon 20 15:30
S16.2
Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Elizabeth Baranowski
Tue 21 11:30
OC10.1
Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Anne Barlier
Mon 20 12:36
OC7.4
Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Maria Barreto-Chaves
Tue 21 15:30
S26.3
Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Isabelle Beau
Tue 21 11:54
OC14.3
Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Moncef Benkhalifa
Mon 20 10:20
S11.1
Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Jerome Bertherat
France
Sun 19 08:05
PEM1.2
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
France
Laura Bessiène
Mon 20 12:12
OC7.2
Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
J. Betley
Mon 20 10:20
S13.1
Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Anneke Beukel
Sun 19 08:25
PEM1.4
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Felix Beuschlein
Zürich, Switzerland
Sun 19 08:15
PEM1.3
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Zürich, Switzerland
Martin Bidlingmaier
Tue 21 08:00
MTE16.2
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Christophe Block
Sun 19 08:00
MTE1
Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Bruce Blumberg
Sun 19 16:00
S7.3
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Jens Bollerslev
Mon 20 09:20
EHM1
Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
Susan Bonner-Weir
Sun 19 17:00
PL3
Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Benjamin Bouillet
Mon 20 11:05
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
Pierre Bouloux
Tue 21 08:00
MTE13
Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Nadia Bouzehouane
Sun 19 12:24
OC4.3
Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Jens Brüning
Tue 21 17:00
PL7
Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Anca Bucur
Mon 20 14:00
NSA4
New Scientific Approach 4
When will AI take over from the endocrinologist?
Alexandre Buffet
Mon 20 12:00
OC5.1
Oral Communications 5: Adrenal 2
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
Edit Buzás
Tue 21 09:50
D4.1
Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Pauline Campos
Tue 21 13:30
NSA6
New Scientific Approach 6
Brain imaging in conscious mice
Carsten Carlberg
Tue 21 13:30
NSA5
New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Davide Carvalho
Mon 20 08:00
MTE7
Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Felipe Casanueva
Sun 19 11:20
SS1.3
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Olivera Casar-Borota
Mon 20 12:00
D3.1
Debate 3: Pituitary Pathology: Do we care?
FOR: Yes, we care about pituitary pathology
Dr Ruth Casey
Cambridge, United Kingdom
Sun 19 12:00
OC1.1
Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Cambridge, United Kingdom
Ashley Castellanos
Mon 20 10:45
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 12:24
OC6.3
Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Patrizio Caturegli
Sun 19 11:20
S4.1
Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Isadora Cavalcante
Tue 21 12:06
OC10.4
Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Carlos Celis-Morales
Mon 20 15:00
S20.1
Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Houaria Chanson
Sun 19 15:45
NDP1.4
Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Kristina Chen
Sun 19 12:36
OC1.4
Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Iacopo Chiodini
Tue 21 10:50
S24.3
Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Emanuel Christ
Mon 20 10:20
S14.1
Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Professor Mirjam Christ-Crain
Basel, Switzerland
Sat 18 18:20
EJE1
Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Basel, Switzerland
Hye Chung
Tue 21 11:54
OC11.3
Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Marc Claret
Mon 20 10:50
S13.2
Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Cyrille Confavreux
Tue 21 08:00
MTE12
Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Martine Cools
Ghent, Belgium
Sun 19 15:30
S8.2
Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ghent, Belgium
Eva Coopmans
Sun 19 12:48
OC3.5
Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Sabrina Corbetta
Sun 19 12:24
OC1.3
Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Valérie Cormier-Daire
Paris, France
Tue 21 10:20
S21.2
Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Paris, France
Mr Sherwin Criseno
Birmingham, UK
Sun 19 11:30
NS1.3
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Birmingham, UK
Daisy Crispim
Tue 21 12:06
OC11.4
Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Dr Rachel Crowley
Dublin, Ireland
Mon 20 10:55
NPD2.2
Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Dublin, Ireland
Michael Culler
Mon 20 12:00
OC6.1
Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Thomas Cuny
Mon 20 11:45
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Closing remarks
Birgitte Damholt
Tue 21 12:06
OC13.4
Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Alberto Davalos
Tue 21 09:50
D4.2
Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Justine Defreyne
Tue 21 12:18
OC12.5
Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Tue 21 11:42
OC14.2
Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Olaf Dekkers
Tue 21 10:50
PS1.3
Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Jacques Drouin
Montreal, Canada
Mon 20 15:00
S17.1
Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Montreal, Canada
Laurence Dumeige
Tue 21 11:42
OC12.2
Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Maeve Durkan
Tue 21 11:45
UEMS1.1
UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Graeme Eisenhofer
Sun 19 15:30
S9.1
Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Eva- Erfurth
Mon 20 11:20
S12.3
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
Eda Ertorer
Mon 20 08:00
MTE10
Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Patrick Fénichel
Mon 20 10:50
S11.2
Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Fernando Fernandez-Aranda
Sun 19 12:00
C1.1
Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Serge Ferrari
Tue 21 14:30
D5.1
<